Skip to main content
永顺生物 logo

永顺生物 — Investor Relations & Filings

Ticker · 920729 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 388 across all filing types
Latest filing 2025-08-25 Governance Information
Country CN China
Listing Beijing Stock Exchange 920729

About 永顺生物

https://www.winsun-gd.com/

Guangdong Winsun Bio-Pharmaceutical Co., Ltd. is a specialized enterprise focused on the research, development, production, and distribution of veterinary biological products. The company primarily develops vaccines for livestock and poultry, with a significant emphasis on swine and avian health. Its product portfolio includes live and inactivated vaccines targeting major diseases such as classical swine fever, porcine reproductive and respiratory syndrome (PRRS), and avian influenza. Winsun Bio-Pharmaceutical leverages advanced biotechnology to provide comprehensive animal disease prevention and control solutions. The company maintains a strong focus on technological innovation and quality management, operating multiple GMP-certified production lines to ensure the efficacy and safety of its biological preparations. Its research initiatives often involve collaborations with academic institutions to advance veterinary medicine and support the animal husbandry sector.

Recent filings

Filing Released Lang Actions
股东会议事规则
Governance Information Classification · 95% confidence The document is titled as the "Shareholders Meeting Rules" of Guangdong Yongshun Biopharmaceutical Co., Ltd., detailing the procedures, rights, and regulations governing the company's shareholder meetings. It includes sections on meeting convening, proposal submission, voting procedures, and legal compliance. There is no indication that this is a report of a meeting, voting results, or an announcement of a report publication. Instead, it is a governance document outlining internal rules and procedures related to shareholder meetings. Therefore, it fits best under Governance Information (CGR). The document length is substantial (over 13,000 characters), indicating it is a full document, not a brief announcement or notice.
2025-08-25 Chinese
董事会战略委员会工作细则
Governance Information Classification · 95% confidence The document is titled as the "Board Strategic Committee Work Rules" of Guangdong Yongshun Biopharmaceutical Co., Ltd. It details the composition, responsibilities, meeting procedures, and governance of the board's strategic committee. There is no financial data, no mention of financial results, no shareholder voting results, no legal proceedings, no capital changes, no earnings information, and no report publication announcement. The document is a governance-related internal rules document about the board committee's operation and structure. Therefore, it fits best under Governance Information (CGR). The document length is 2871 characters, which is consistent with a detailed governance policy document rather than a brief announcement or report publication notice.
2025-08-25 Chinese
承诺管理制度
Regulatory Filings Classification · 95% confidence The document is a formal announcement from Guangdong Yongshun Biopharmaceutical Co., Ltd. regarding the adoption and revision of an internal management system called the 'Commitment Management System.' It details the board meeting resolutions, voting results, and the content of the management system. The document is a regulatory announcement about corporate governance and internal management policies, not a financial report or earnings release. It does not contain financial statements or data, nor does it announce voting results from a shareholder meeting. It is not a proxy solicitation or remuneration report. The document is relatively short (1955 characters) and focuses on governance and compliance matters. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-08-25 Chinese
关联交易管理制度
Governance Information Classification · 95% confidence The document is titled as a management system for related party transactions (关联交易管理制度) issued by Guangdong Yongshun Biopharmaceutical Co., Ltd. It details the company's internal rules and procedures for managing related party transactions, including definitions, decision-making authority, review processes, and disclosure requirements. The document is a formal policy or governance document rather than a financial report or announcement of voting results. It does not contain financial statements or earnings data, nor is it a transcript or presentation. It is not an announcement of a report publication but a detailed governance-related document. Therefore, it fits best under Governance Information (CGR). The document length (7482 characters) supports it being a substantive policy document rather than a brief announcement.
2025-08-25 Chinese
网络投票制度实施细则
Governance Information Classification · 95% confidence The document is a detailed internal regulation titled '网络投票制度实施细则' (Network Voting System Implementation Rules) issued by the board of Guangdong Yongshun Biopharmaceutical Co., Ltd. It outlines the procedures and rules for shareholder voting via an online system, including preparation, voting rules, and legal compliance. It is not a financial report, earnings release, or announcement of voting results. It is a governance-related document detailing internal rules and procedures for shareholder meetings and voting mechanisms. Therefore, it fits best under Governance Information (CGR). The document length is 2402 characters, which is sufficient for a detailed governance report rather than a brief announcement or notice.
2025-08-25 Chinese
关于董事、高级管理人员薪酬方案的公告
Remuneration Information Classification · 95% confidence The document is an announcement regarding the remuneration scheme for the company's directors and senior management. It details the salary standards, approval process, and implementation timeline for the remuneration plan. It does not contain financial statements or performance data but focuses on compensation policies and governance related to executive pay. This matches the definition of a Remuneration Information filing, which reports compensation details for top executives and directors. The document length is short and it is not a report or presentation but a formal announcement of the remuneration plan.
2025-08-25 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.